Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Fuji
Harvard Business School
Federal Trade Commission
AstraZeneca
Dow
Chubb
Merck
Accenture
Fish and Richardson
Boehringer Ingelheim

Generated: August 17, 2017

DrugPatentWatch Database Preview

King Pharms Llc Company Profile

« Back to Dashboard

What is the competitive landscape for KING PHARMS LLC, and when can generic versions of KING PHARMS LLC drugs launch?

KING PHARMS LLC has nine approved drugs.

There is one US patent protecting KING PHARMS LLC drugs.

There are twelve patent family members on KING PHARMS LLC drugs in twelve countries.

Summary for Applicant: King Pharms Llc

Patents:1
Tradenames:9
Ingredients:8
NDAs:9
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
King Pharms Llc
BICILLIN L-A
penicillin g benzathine
INJECTABLE;INJECTION050141-003Approved Prior to Jan 1, 1982RXYesYes► Subscribe► Subscribe► Subscribe
King Pharms Llc
INTAL
cromolyn sodium
AEROSOL, METERED;INHALATION018887-001Dec 5, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe
King Pharms Llc
BICILLIN C-R
penicillin g benzathine; penicillin g procaine
INJECTABLE;INJECTION050138-002Approved Prior to Jan 1, 1982RXYesYes► Subscribe► Subscribe► Subscribe
King Pharms Llc
INTAL
cromolyn sodium
SOLUTION;INHALATION018596-001May 28, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
King Pharms Llc
PENICILLIN G PROCAINE
penicillin g procaine
INJECTABLE;INJECTION060101-002Approved Prior to Jan 1, 1982RXNoYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for King Pharms Llc

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
King Pharms Llc
INTAL
cromolyn sodium
AEROSOL, METERED;INHALATION018887-001Dec 5, 1985► Subscribe► Subscribe
King Pharms Llc
CORZIDE
bendroflumethiazide; nadolol
TABLET;ORAL018647-001May 25, 1983► Subscribe► Subscribe
King Pharms Llc
INTAL
cromolyn sodium
AEROSOL, METERED;INHALATION018887-001Dec 5, 1985► Subscribe► Subscribe
King Pharms Llc
INTAL
cromolyn sodium
SOLUTION;INHALATION018596-001May 28, 1982► Subscribe► Subscribe
King Pharms Llc
CORZIDE
bendroflumethiazide; nadolol
TABLET;ORAL018647-002May 25, 1983► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for KING PHARMS LLC drugs

Drugname Dosage Strength Tradename Submissiondate
morphine sulfate
Extended-release Capsules45 mg and 75 mg
AVINZA
7/30/2009
morphine sulfate
Extended-release Capsules30 mg, 60 mg, 90 mg and 120 mg
AVINZA
6/4/2007

International Patent Family for King Pharms Llc Drugs

Country Document Number Estimated Expiration
Canada2558783► Subscribe
Denmark1023051► Subscribe
Japan4535613► Subscribe
Spain2199378► Subscribe
South Africa9809463► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Colorcon
Fish and Richardson
Cantor Fitzgerald
Julphar
Argus Health
Merck
Healthtrust
Fuji
Johnson and Johnson
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot